Wells Fargo Reiterates Overweight Rating on Target Corporation (TGT)
Wells Fargo reiterated its Overweight rating on Target Corporation (NYSE:TGT) on August 20, 2026.
Read moreReal-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Wells Fargo reiterated its Overweight rating on Target Corporation (NYSE:TGT) on August 20, 2026.
Read moreStifel reiterated its Hold rating on Zoetis Inc. (NYSE:ZTS) on August 20, 2026.
Read moreGuggenheim reiterated its Buy rating on Autodesk, Inc. (NASDAQ:ADSK) on August 20, 2026.
Read moreCitigroup reiterated its Neutral rating on Autodesk, Inc. (NASDAQ:ADSK) on August 20, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Korro Bio, Inc.
Read moreBenchmark analysts initiated coverage on SiTime Corporation (NASDAQ:SITM) with a rating of Buy on August 20, 2026.
Read moreCitizens analysts initiated coverage on Builders FirstSource, Inc. (NYSE:BLDR) with a rating of Market Perform on August 21, 2026.
Read moreLUCID CAPITAL MARKETS analysts initiated coverage on Eloxx Pharmaceuticals, Inc. (OTC:ELOX) with a rating of Buy on August 20, 2026.
Read moreAscendiant Capital reiterated its Buy rating on Travelzoo (NASDAQ:TZOO) on August 20, 2026.
Read moreWilliam Blair analysts initiated coverage on Surrozen, Inc. (NASDAQ:SRZN) with a rating of Outperform on August 20, 2026.
Read moreBaird analysts initiated coverage on Covenant Logistics Group, Inc. (NASDAQ:CVLG) with a rating of Outperform on August 20, 2026.
Read moreCitigroup reiterated its Sell rating on Gemini Space Station, Inc. Class A Common Stock (NASDAQ:GEMI) on August 20, 2026.
Read moreTruist Securities reiterated its Buy rating on PagerDuty, Inc. (NYSE:PD) on August 20, 2026.
Read moreWells Fargo analysts initiated coverage on Progyny, Inc. (NASDAQ:PGNY) with a rating of Overweight on August 20, 2026.
Read moreGLJ Research analysts downgraded Fluence Energy, Inc. (NASDAQ:FLNC) from Buy to Hold on August 20, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) on August 20, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) on August 20, 2026.
Read moreCitigroup reiterated its Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) on August 20, 2026.
Read moreWells Fargo reiterated its Overweight rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) on August 20, 2026.
Read moreTruist Securities reiterated its Hold rating on GitLab Inc. (NASDAQ:GTLB) on August 20, 2026.
Read more